Fig. 1From: A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countriesPatient disposition. AE adverse event. aDMF, delayed-release DMF. bReasons for discontinuation documented by investigators were gastrointestinal intolerance for study medication, moved, plasmapheresis, and positive urine pregnancy testBack to article page